10
The following cases were also shown: Family history: One brother and one sister are similarly affected. There are two other unaffected sibs. The parents are not known to be related, but they both derive from the same area of a small country town, so that consanguinity is possible.
Case 3 (for J Morgan MD) Man aged 25, with chronic oral candidiasis since the age of three months, and repeated chest in-fections as a boy. In addition to the lesions in his mouth he has candidal blepharitis, laryngitis, paronychie resulting in gross deformity of some nails, intertrigo in both axille and balanoposthitis.
Family history: There are 5 unaffected sibs; again, although there is no proven consanguinity, this is possible.
Investigations: This patient has been very extensively investigated at Guy's Hospital without success in identifying a specific causative factor. It is probably worth noting that his serum vitamin A and serum carotene were both low on repeated examination. He had a trial of treatment with 5-fluorocytosine, but it had to be discontinued because he developed a drug eruption. Clinically he was much improved with this treatment.
Discussion
Genetic aspects: A preliminary genetic classification is given in Table 1 . I have now seen 18 patients who are probably in Group 1. Four of these are sporadic cases, but the rest have one or more sibs affected. Of the 10 pedigrees, consan- guinity has been proven in 4, is possible in 5 and unlikely in one. No instances are known where the parent or child of an affected individual has the disorder. Autosomal recessive inheritance is strongly supported by the-genetic analysis.
In Group 2 there are 12 patients, and these are all more severely affected, and some have bronchiectasis. Three have died. Apart from one individual with a doubtfully affected sib, they are all sporadic cases, so that they may be the possessors of a new autosomal dominant mutation.
Group 3 is a well-recognized syndrome which is inherited as an autosomal recessive trait, and I have seen 3 patients in this group.
Clinical aspects: The clinical manifestations vary in severity, and some patients have other associated features; they may have an abnormality in common:
(1) A disorder of oral keratinization: Histological studies and the widespread lesions in some patients do not support this hypothesis.
(2) Pathogenic canidida: Although Dr Yvonne Clayton has grown different types of candida from some of the patients, there is nothing to suggest a pathogenic strain different from the types that are more usually cultured.
(3) A disorder ofimmunity: This would seem to be the most reasonable hypothesis at the present time, but the position is extremely complex. This group of patients is probably a good example of clinical and genetic heterogeneity. I started with the hypothesis that the first group of patients might have a qualitative or quantitative abnormality of their salivary and serum IgA, but preliminary results do not seem to support this. Only a few of the children have shown a low salivary IgA.
Chronic candidal infections have been reported in individuals with a deficiency of myeloperoxidase (Lehner & Cline 1969) . Seven of my patients have now been examined by Professor R Hardisty and do not show an absence of myeloperoxidase in their white cells. Alternatively some may have an abnormality of their migratory inhibitory factor, as suggested by Chilgren et al. (1969) and this possibility is being investigated by Dr P Holt and Dr J Hobbs at the Hammersmith Hospital. Chronic granulomatous disease is another possible diagnosis (Thompson & Soothill 1970) . Summary I suggest there is a group of patients with chronic oral candidiasis, which may be associated with other abnormalities, and where there are several different possible causes. In some at least the abnormality is genetically determined and inherited as an autosomal recessive trait. Dr Yvonne Clayton: There are, as yet, no laboratory tests available which enable a significant assessment to be made as to the relative pathogenicity of different isolates of Candida albicans. Two antigenic groups, A and B, are recognized within the species but there is little evidence that one antigenic group is more pathogenic for humans than the other. Dr John Garrod: 5-fluorocytosine is a new antifungal agent which has been studied in a very limited number of cases; these have been mainly terminal or have not responded to other drugs. Problems related to the safety and toxicity of this research compound are still being investigated.
Dr A J E Barlow: The child with generalized candidiasis, to whom Dr Wells referred, was originally under the care of Dr Sweetnam and myself. He was found to be suffering from mucoviscidosis during the first year of life, and following treatment by antibiotics he developed generalized candidiasis. To the best of my knowledge, there was no history of consanguinity.
We also had another boy similarly affected. He was well until about 12 months old, when he developed pneumonia. This was treated by antibiotics and he subsequently developed bronchiectasis, followed by extensive oral and skin candidiasis. This was resistant to all topical applications, but cleared completely after prolonged, continuous, intravenous amphotericin B. There was, however, a gradual and complete relapse over a period of months. He died a few years later about the age of 10. Histology at the autopsy showed extensive invasion of the oral cavity and all keratinized tissues by Candida albicans. The lungs consisted mostly of fibrous tissue and, in pieces selected, there was no evidence of C. albicans. The other organs were not infected.
We have examined several hundred sera for the socalled anticandicidal activity of serum and in all cases C. albicans has grown freely, so we doubt whether there is any candicidal activity in serum. It is also difficult to see how polymorphs are able, in vivo, to ingest C. albicans. Germ tube formation takes place as soon as it is placed in serum and mechanical factors alone would make ingestion by a polymorph most unlikely.
Dr R S Wells: The problem with many of the published papers is that they are describing patients in different groups. A preliminary genetic classification is essential.
